SOLARA ACTIVE PHARMA [SOLARAPP1] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

SOLARA ACTIVE PHARMA SCIENCES

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: SOLARA ACTIVE PHARMA SCIENCES wins in 7 metrics, Innova Captab Ltd. wins in 12 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric SOLARA ACTIVE PHARMA SCIENCES Innova Captab Ltd. Better
P/E Ratio (TTM) 300.92 31.20 Innova Captab Ltd.
Price-to-Book Ratio 1.05 4.05 SOLARA ACTIVE PHARMA SCIENCES
Debt-to-Equity Ratio 51.38 32.95 Innova Captab Ltd.
PEG Ratio -1.02 1.33 Innova Captab Ltd.
EV/EBITDA 11.85 20.49 SOLARA ACTIVE PHARMA SCIENCES
Profit Margin (TTM) -1.52% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 3.37% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 3.37% 12.88% Innova Captab Ltd.
Return on Equity 0.05% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 0.02% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $1.73B $-1.09B SOLARA ACTIVE PHARMA SCIENCES
Dividend Yield N/A 0.30% N/A
1-Year Return 13.08% -3.19% SOLARA ACTIVE PHARMA SCIENCES
Price-to-Sales Ratio (TTM) 1.66 2.76 SOLARA ACTIVE PHARMA SCIENCES
Enterprise Value $19.97B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 1.59 2.90 SOLARA ACTIVE PHARMA SCIENCES
Gross Profit Margin (TTM) 46.53% 35.19% SOLARA ACTIVE PHARMA SCIENCES
Revenue per Share (TTM) $231 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $-4.82 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.84 -0.33 Innova Captab Ltd.

SOLARA ACTIVE PHARMA SCIENCES vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

SOLARAPP1
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
SOLARA ACTIVE PHARMA SCIENCES12.87%2.56%2.47%-20.88%-31.50%-20.88%
Innova Captab Ltd.1.81%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
SOLARA ACTIVE PHARMA SCIENCES13.08%31.31%31.31%31.31%31.31%31.31%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Innova Captab Ltd.

MetricSOLARAPP1INNOVACAP
Market Information
Market Cap i₹20.78B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i238578,151
90 Day Avg. Volume i704217,693
Last Close₹308.70₹872.55
52 Week Range₹247.95 - ₹511.00₹622.00 - ₹1,020.70
% from 52W High-39.59%-14.51%
All-Time High₹511.00 (Aug 29, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-39.59%-30.75%
Growth Metrics
Quarterly Revenue Growth0.16%0.42%
Quarterly Earnings Growth0.16%0.23%
Financial Health
Profit Margin (TTM) i-0.02%0.09%
Operating Margin (TTM) i0.03%0.13%
Return on Equity (TTM) i0.00%0.13%
Debt to Equity (MRQ) i51.3832.95
Cash & Liquidity
Book Value per Share (MRQ)₹293.20₹178.28
Cash per Share (MRQ)₹0.88₹10.22
Operating Cash Flow (TTM) i₹1.70B₹282.88M
Levered Free Cash Flow (TTM) i₹5.40M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Innova Captab Ltd.

MetricSOLARAPP1 (Apr 08, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i300.9231.20
Forward P/E iN/A21.90
PEG Ratio i-1.021.33
Price to Sales (TTM) i1.662.76
Price to Book (MRQ) i1.054.05
Market Capitalization
Market Capitalization i₹20.78B₹41.43B
Enterprise Value i₹19.97B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i1.592.90
Enterprise to EBITDA i11.8520.49
Risk & Other Metrics
Beta i0.84-0.33
Book Value per Share (MRQ) i₹293.20₹178.28

Financial Statements Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSOLARAPP1 (2025)INNOVACAP (2025)
Revenue/Sales i12.41B12.34B
Cost of Goods Sold i6.46B8.38B
COGS % of Revenue i52.0%67.9%
Gross Profit i5.96B3.96B
Gross Margin i48.0%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i1.11B1.65B
Operating Margin i9.0%13.4%
EBITDA i2.05B2.00B
EBITDA Margin i16.5%16.2%
Pre-Tax Income i5.40M1.71B
Pre-Tax Income % of Revenue i0.0%13.9%
Income Tax i0427.58M
Income Tax % of Revenue i0.0%3.5%
Net Income (Profit) i5.40M1.28B
Profit Margin i0.0%10.4%

Balance Sheet & Liquidity Metrics

MetricSOLARAPP1 (2025)INNOVACAP (2025)
Cash & Equivalents i39.50M155.19M
Total Current Assets i7.29B7.03B
Total Current Assets % of Revenue i58.7%57.0%
Total Current Liabilities i9.44B3.53B
Total Current Liabilities % of Revenue i76.0%28.6%
Long-Term Debt i1.32B2.45B
Long-Term Debt % of Revenue i10.6%19.8%
Total Shareholders Equity i10.97B9.59B
Retained Earnings i-3.16B4.53B
Retained Earnings % of Revenue i-25.4%36.7%
Property, Plant & Equipment i7.96B442.93M

Cash Flow Statement Comparison

MetricSOLARAPP1 (2025)INNOVACAP (2025)
Operating Cash Flow i1.70B282.88M
Operating Cash Flow % of Revenue i13.7%2.3%
Capital Expenditures i3.80M-1.72B
Free Cash Flow i1.73B-1.09B
FCF Margin i13.9%-8.8%
Debt Repayment i-1.11B-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSOLARAPP1INNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.00M57.22M
Float Shares i30.10M15.91M
% Held by Insiders i0.00%72.19%
% Held by Institutions i4.45%19.22%
% Held by Public i95.55%8.59%

Dividend Analysis & Yield Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Innova Captab Ltd.

MetricSOLARAPP1INNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026